English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Methicillin-resistant Staphylococcus aureus (MRSA) is an increasingly common cause of bacteremia and endocarditis. The cost-effectiveness (CE) of daptomycin was compared with that of vancomycin-gentamicin in patients with MRSA bacteremia with or without endocarditis.

clinical infectious diseases/clinical infectious diseases (online. university of chicago. press)

Cost‐Effectiveness of Daptomycin versus Vancomycin and Gentamicin for Patients with Methicillin‐Resistant<i>Staphylococcus aureus</i>Bacteremia and/or Endocarditis

Cost‐Effectiveness of Daptomycin versus Vancomycin and Gentamicin for Patients with Methicillin‐ResistantStaphylococcus aureusBacteremia and/or Endocarditis